AEP is also actively working to introduce the products into grocery chains in the area around its home time of Columbus, Ohio. Bexsa sells its products locally, and plans to export fresh mushrooms to neighboring countries and dried mushrooms worldwide. It also prepares packaged foods from the trimmings of its edible mushrooms and is researching other fungi with applications in clothing dye, decomposition of industrial waste and medicine. The Canopy investment will allow Bexsa to expand its capacity, enter the international market, and strengthen its management systems. The founding genius behind Bexsa is Niels Prahm and Canopy structured the transaction to incentivise him to institutionalize his technical and management expertise within Bexsa.
Canopy continues to explore other opportunities.
With help from FAN Sciences, it is developing Bolivian medicinal plants and herbs to introduce into nutritional supplement markets in the US and Europe. Canopy is also formulating a joint venture with a US manufacturer of botanical supplements that would include building a botanical extraction facility in Bolivia. Canopy will likely have some involvement with plant tissue services and ornamental plants, principally orchids, in conjunction with FAN Sciences. FAN is also designing a line of gold and silver jewelry based on rare Bolivian orchids to be marketed by Canopy. The company intends remaining flexible and persistent in pursuing endeavors compatible with the overall objectives of the Noel Kempff project.